Connecting industry and ASPR to bolster resiliency across the entire public health and medical industrial base
The COVID-19 pandemic has shown the importance of a nimble supply chain that is flexible enough to rapidly change manufacturing volumes and products in response to fluctuations in demand during a crisis. Keeping the nation’s public health and medical supply chains secure, robust, and resilient is essential for national security and the economic prosperity of the United States.
ASPR is seeking information from stakeholders on manufacturing solutions that can be applied to platform technologies; drug substance and drug products; personal protective equipment (PPE); vaccines; and testing and diagnostic devices and consumable components. We are particularly interested in products and technologies that have progressed into or beyond clinical trials and are currently being produced at scale or utilize an approved platform.
To get started, submit a request to our team of experts about your solution through IBx Connect. A member of our team will evaluate your submission and determine if a meeting is right at this time based on ASPR’s industrial base expansion priorities. If selected, your company will be given the opportunity to engage with our experts and receive feedback on your proposed solutions.